BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1311880)

  • 1. Pharmacological strategies in CNS trauma.
    Faden AI; Salzman S
    Trends Pharmacol Sci; 1992 Jan; 13(1):29-35. PubMed ID: 1311880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment of central nervous system trauma.
    Faden AI
    Pharmacol Toxicol; 1996 Jan; 78(1):12-7. PubMed ID: 8685080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of thyrotropin-releasing hormone and opiate receptor antagonists in limiting central nervous system injury.
    Faden AI
    Adv Neurol; 1988; 47():531-46. PubMed ID: 2830771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate-receptor antagonists, thyrotropin-releasing hormone (TRH), and TRH analogs in the treatment of spinal cord injury.
    Faden AI
    Cent Nerv Syst Trauma; 1987; 4(4):217-26. PubMed ID: 3128405
    [No Abstract]   [Full Text] [Related]  

  • 5. New pharmacologic approaches to spinal cord injury: opiate antagonists and thyrotropin-releasing hormone.
    Faden AI
    Cent Nerv Syst Trauma; 1985; 2(1):5-8. PubMed ID: 3004747
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacotherapy in spinal cord injury: a critical review of recent developments.
    Faden AI
    Clin Neuropharmacol; 1987 Jun; 10(3):193-204. PubMed ID: 2842048
    [No Abstract]   [Full Text] [Related]  

  • 7. Should we treat concussion pharmacologically? The need for evidence based pharmacological treatment for the concussed athlete.
    McCrory P
    Br J Sports Med; 2002 Feb; 36(1):3-5. PubMed ID: 11867481
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuropeptides and central nervous system injury. Clinical implications.
    Faden AI
    Arch Neurol; 1986 May; 43(5):501-4. PubMed ID: 2870700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate antagonists and thyrotropin-releasing hormone. II. Potential role in the treatment of central nervous system injury.
    Faden AI
    JAMA; 1984 Sep; 252(11):1452-4. PubMed ID: 6433052
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute spinal cord injury, part II: contemporary pharmacotherapy.
    Dumont RJ; Verma S; Okonkwo DO; Hurlbert RJ; Boulos PT; Ellegala DB; Dumont AS
    Clin Neuropharmacol; 2001; 24(5):265-79. PubMed ID: 11586111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The physiopathology of acute spinal cord injury and a hope for a successful treatment].
    Harat M; Radek A; Kochanowski J
    Neurol Neurochir Pol; 1996; 30(1):123-35. PubMed ID: 8657340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review.
    McIntosh TK
    J Neurotrauma; 1993; 10(3):215-61. PubMed ID: 8258838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology and treatment of spinal cord medulla injuries].
    Kochanowski J; Malara A; Chudzik W; Kaczorowska B
    Neurol Neurochir Pol; 1999; 32 Suppl 6():91-7. PubMed ID: 11107569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studies.
    Faden AI
    Brain Res; 1989 May; 486(2):228-35. PubMed ID: 2499400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of TRH analogs on neurologic recovery after experimental spinal trauma.
    Faden AI; Jacobs TP
    Neurology; 1985 Sep; 35(9):1331-4. PubMed ID: 3927187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the NMDA ion-channel blocker, aptiganel hydrochloride, as a neuroprotective agent for acute CNS injury.
    McBurney RN
    Int Rev Neurobiol; 1997; 40():173-95. PubMed ID: 8989621
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neuronal protection in neurologic diseases?].
    Bähr M; Eschweiler GW; Dichgans J
    Nervenarzt; 1994 Jun; 65(6):355-60. PubMed ID: 8072588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies.
    Juurlink BH; Paterson PG
    J Spinal Cord Med; 1998 Oct; 21(4):309-34. PubMed ID: 10096045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opiate antagonists in shock and trauma.
    Holaday JW
    Am J Emerg Med; 1984 Jan; 2(1):8-12. PubMed ID: 6097276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury.
    Hall ED; Yonkers PA; Andrus PK; Cox JW; Anderson DK
    J Neurotrauma; 1992 May; 9 Suppl 2():S425-42. PubMed ID: 1613805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.